<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">46551</article-id><article-id pub-id-type="doi">10.7554/eLife.46551</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Short Report</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group></article-categories><title-group><article-title>NRG1 is a critical regulator of differentiation in TP63-driven squamous cell carcinoma</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-133467"><name><surname>Hegde</surname><given-names>Ganapati V</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6473-153X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-134053"><name><surname>de la Cruz</surname><given-names>Cecile</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-61197"><name><surname>Giltnane</surname><given-names>Jennifer M</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf4"/></contrib><contrib contrib-type="author" id="author-134054"><name><surname>Crocker</surname><given-names>Lisa</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf5"/></contrib><contrib contrib-type="author" id="author-142173"><name><surname>Venkatanarayan</surname><given-names>Avinashnarayan</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf6"/></contrib><contrib contrib-type="author" id="author-134055"><name><surname>Schaefer</surname><given-names>Gabriele</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf7"/></contrib><contrib contrib-type="author" id="author-134056"><name><surname>Dunlap</surname><given-names>Debra</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf8"/></contrib><contrib contrib-type="author" id="author-134057"><name><surname>Hoeck</surname><given-names>Joerg D</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf9"/></contrib><contrib contrib-type="author" id="author-134058"><name><surname>Piskol</surname><given-names>Robert</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf10"/></contrib><contrib contrib-type="author" id="author-134182"><name><surname>Gnad</surname><given-names>Florian</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf11"/></contrib><contrib contrib-type="author" id="author-83828"><name><surname>Modrusan</surname><given-names>Zora</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="conf12"/></contrib><contrib contrib-type="author" id="author-7128"><name><surname>de Sauvage</surname><given-names>Frederic J</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="conf13"/></contrib><contrib contrib-type="author" id="author-134060"><name><surname>Siebel</surname><given-names>Christian W</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf14"/></contrib><contrib contrib-type="author" corresp="yes" id="author-134061"><name><surname>Jackson</surname><given-names>Erica L</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7100-8021</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="fn" rid="conf15"/></contrib><aff id="aff1"><institution content-type="dept">Discovery Oncology</institution>, <institution>Genentech Inc</institution>, <addr-line><named-content content-type="city">South San Francisco</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Translational Oncology</institution>, <institution>Genentech Inc</institution>, <addr-line><named-content content-type="city">South San Francisco</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">Department of Pathology</institution>, <institution>Genentech Inc</institution>, <addr-line><named-content content-type="city">South San Francisco</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><institution content-type="dept">Pathology</institution>, <institution>Genentech Inc</institution>, <addr-line><named-content content-type="city">South San Francisco</named-content></addr-line>, <country>United States</country></aff><aff id="aff5"><institution content-type="dept">Molecular Oncology</institution>, <institution>Genentech Inc</institution>, <addr-line><named-content content-type="city">South San Francisco</named-content></addr-line>, <country>United States</country></aff><aff id="aff6"><institution content-type="dept">Bioinformatics</institution>, <institution>Genentech Inc</institution>, <addr-line><named-content content-type="city">South San Francisco</named-content></addr-line>, <country>United States</country></aff><aff id="aff7"><institution content-type="dept">Department of Molecular Biology</institution>, <institution>Genentech Inc</institution>, <addr-line><named-content content-type="city">South San Francisco</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-5558"><name><surname>Hahn</surname><given-names>William C</given-names></name><role>Reviewing editor</role><aff><institution>Dana-Farber Cancer Institue</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>gvhegde@gmail.com</email> (GH);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>ericajackso@gmail.com</email> (EJ);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>30</day><month>05</month><year>2019</year></pub-date><volume>8</volume><elocation-id>e46551</elocation-id><history><date date-type="received"><day>04</day><month>03</month><year>2019</year></date><date date-type="accepted"><day>28</day><month>05</month><year>2019</year></date></history><permissions><copyright-statement>Â© 2019, Hegde et al</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Hegde et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-46551-v1.pdf"/><abstract><p>Squamous cell carcinomas (SCCs) account for the majority of cancer mortalities. Although TP63 is an established lineage-survival oncogene in SCCs, therapeutic strategies have not been developed to target TP63 or it's downstream effectors. In this study we demonstrate that TP63 directly regulates NRG1 expression in human SCC cell lines and that NRG1 is a critical component of the TP63 transcriptional program. Notably, we show that squamous tumors are dependent NRG1 signaling <italic>in vivo</italic>, in both genetically engineered mouse models and human xenograft models, and demonstrate that inhibition of NRG1 induces keratinization and terminal squamous differentiation of tumor cells, blocking proliferation and inhibiting tumor growth. Together, our findings identify a lineage-specific function of NRG1 in SCCs of diverse anatomic origin.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Mouse</kwd></kwd-group><funding-group><funding-statement>The authors declare that there was no funding for this work</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Ganapati V Hegde, employee of Genentech Inc at the time of participation in this study.</p></fn><fn fn-type="conflict" id="conf3"><p>Cecile de la Cruz, employee of Genentech Inc at the time of participation in this study.</p></fn><fn fn-type="conflict" id="conf4"><p>Jennifer M Giltnane, employee of Genentech Inc at the time of participation in this study.</p></fn><fn fn-type="conflict" id="conf5"><p>Lisa Crocker, employee of Genentech Inc at the time of participation in this study.</p></fn><fn fn-type="conflict" id="conf6"><p>Avinashnarayan Venkatanarayan, employee of Genentech Inc at the time of participation in this study.</p></fn><fn fn-type="conflict" id="conf7"><p>Gabriele Schaefer, employee of Genentech Inc at the time of participation in this study.</p></fn><fn fn-type="conflict" id="conf8"><p>Debra Dunlap, employee of Genentech Inc at the time of participation in this study.</p></fn><fn fn-type="conflict" id="conf9"><p>Joerg D Hoeck, employee of Genentech Inc at the time of participation in this study.</p></fn><fn fn-type="conflict" id="conf10"><p>Robert Piskol, employee of Genentech Inc at the time of participation in this study.</p></fn><fn fn-type="conflict" id="conf11"><p>Florian Gnad, employee of Genentech Inc at the time of participation in this study.</p></fn><fn fn-type="conflict" id="conf12"><p>Zora Modrusan, employee of Genentech Inc at the time of participation in this study.</p></fn><fn fn-type="conflict" id="conf13"><p>Frederic J de Sauvage, employee of Genentech Inc at the time of participation in this study.</p></fn><fn fn-type="conflict" id="conf14"><p>Christian W Siebel, employee of Genentech Inc at the time of participation in this study.</p></fn><fn fn-type="conflict" id="conf15"><p>Erica L Jackson, employee of Genentech Inc at the time of participation in this study.</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All animal studies were approved by the Institutional Animal Care and Use Committee (IACUC) at Genentech.  The animal studies included herein were performed based on approved IACUC protocol numbers (LASAR 10-2319A, 16-1304, 16-1304A, 16-0098, 16-1120, 16-1143 and 16-2005, 16-1120).</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files. Source data file has been provided for Figure 4.</p></sec><supplementary-material><ext-link xlink:href="elife-46551-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>